Word: six
(lookup in dictionary)
(lookup stats)
Dates: during 1950-1959
Sort By: most recent first
(reverse)
...Radio Corp. established a first-half record with earnings of $1.66 per share v. $1.01 last year, but lost 14⅛ points during the week. Philco Corp. came back from a $1,400,000 loss in the first half last year to earn 54? per share for the first six months of 1959, was off 2⅞ for the week. Motorola, which set a second-half record with $3.04 per share v. 76? last year, dipped seven points...
...Toyopet was once the tinny target of G.I. gibes ("If you strip off the door lining, you can read the beer-can labels"), streamlined Toyopet to resemble in performance and size a compact U.S. car (14⅓ ft. long v. Rambler's 14½ ft.). The four-door, six-passenger Toyopet has a 65-h.p. motor, does more than 30 miles on a gallon of gas, sells for $2,239 at port of entry...
...mastermind the family merger, Getty appointed his affable, efficient son, George Franklin Getty II, 35, who has spent only six weeks with his father since the first year of his life, still refers to him as "Mr. Getty." But his father keeps in close touch on business matters, sends him as many as 20 notes a week from abroad. George, who quit Princeton after only one year ("I knew I wanted to go into the oil business, so why waste time?"), has been put in charge of streamlining the Getty domain. He worked in most of its outposts, was made...
...botulism, and only moderately effective at best, is a Ledejle Laboratories antitoxin (made by injecting botulinus toxin into horses and extracting their immune serum). It costs about $68 a 20,000-unit vial, and each victim needs at least 50,000 units. Nearest supply was in Portland, Ore.: six vials. More was flown from Denver and Los Angeles. Still not enough. At its Pearl River (N.Y.) headquarters, Lederle drained the barrel, packaged nearly all the remaining antitoxin. Total haul: 139 vials, tagged at $9.591-which Lederle marked "paid," as a public service...
Just when polio vaccine was needed most, supplies were thin and spotty. Reason : spurts and lags in public demand have bedeviled the vaccine makers. Last year Eli Lilly & Co. alone destroyed n million doses for lack of takers (the vaccine deteriorates after six months). This year the U.S. Public Health Service has asked manufacturers to cut out exports. Both Lilly and Merck Sharp & Dohme laboratories have stepped up output; U.S. production to date (from five manufacturers) is up to more than 50 million doses-10% ahead of last year. But last week, with the belated demand for shots running ahead...